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Proteostasis in dendritic cells is controlled by the PERK
signaling axis independently of ATF4
Andreia Mendes1,2,3,* , Julien P Gigan1,*, Christian Rodriguez Rodrigues1 , Sébastien A Choteau1,6 , Doriane Sanseau4,
Daniela Barros1,2,3, Catarina Almeida2,3 , Voahirana Camosseto1,3,4, Lionel Chasson1, AdrienneW Paton5, James C Paton5,
Rafael J Argüello1,4 , Ana-Maria Lennon-Duménil4, Evelina Gatti1,2,3,4 , Philippe Pierre1,2,3,4
In stressed cells, phosphorylation of eukaryotic initiation factor
2α (eIF2α) controls transcriptome-wide changes in mRNA trans-
lation and gene expression known as the integrated stress re-
sponse. We show here that DCs are characterized by high eIF2α
phosphorylation, mostly caused by the activation of the ER kinase
PERK (EIF2AK3). Despite high p-eIF2α levels, DCs display active
protein synthesis and no signs of a chronic integrated stress
response. This biochemical specificity prevents translation arrest
and expression of the transcription factor ATF4 during ER-stress
induction by the subtilase cytotoxin (SubAB). PERK inactivation,
increases globally protein synthesis levels and regulates IFN-β
expression, while impairing LPS-stimulated DC migration. Al-
though the loss of PERK activity does not impact DC development,
the cross talk existing between actin cytoskeleton dynamics;
PERK and eIF2α phosphorylation is likely important to adapt DC
homeostasis to the variations imposed by the immune contexts.
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Introduction
DCs are key regulators of both protective immune responses and
tolerance to self-antigens (Dalod et al, 2014). DCs are professional
APCs, equipped with pattern recognition receptors (PRRs), capable
of recognizing microbe-associated molecular patterns (MAMPs)
(Akira et al, 2006) and enhance their immunostimulatory activity
(Steinman, 2007). MAMPs detection by DCs triggers the process of
maturation/activation, which culminates in the unique capacity of
priming naı̈ve T cells in lymphoid organs. LPS detection by TLR4
promotes DCs maturation by triggering a series of signaling cas-
cades resulting in secretion of polarizing and inflammatory cyto-
kines, up-regulation of co-stimulatory molecules, as well as
enhanced antigen processing and presentation (Mellman, 2013). All
these functions are accompanied by major remodeling of mem-
brane trafficking and actin organization to favor both antigen
capture and migration to the lymph nodes (West et al, 2004;
Chabaud et al, 2015; Arguello et al, 2016; Bretou et al, 2017).
Upon activation by MAMPs, like LPS, a large augmentation of protein
synthesis, representing a two to fivefold increase above resting state,
occurs in DCs. This is required for the up-regulation of co-stimulatory
molecules at the cell surface and acquires T-cell immune-
stimulatory function (Lelouard et al, 2007; Reverendo et al, 2019).
The phosphorylation of eukaryotic initiation factor 2 (eIF2) is a
central hub for regulating protein synthesis during stress. In ho-
meostatic conditions, eIF2 mediates the assembly of the mRNA
translation initiation complex and regulates start codon recogni-
tion. During stress, phosphorylation of the α subunit of eIF2 (eIF2α)
on serine 51 is mediated by a group of four eIF2α kinases (EIF2AK1-
4), which specifically senses physiological imbalance (Arguello et al,
2016; Costa-Mattioli & Walter, 2020). Phosphorylation of eIF2α
converts eIF2 into an inhibitor of the GDP–GTP guanidine
exchange factor eIF2B, impairing the GDP–GTP recycling required
to form new translation initiation complexes (Yamasaki & Anderson,
2008). Consequently, increased eIF2α phosphorylation impacts cells in
twomainways: (i) By reducing the rate of translation initiation and thus
global protein synthesis levels; (ii) By favoring the translation of the
activating transcription factor 4 (ATF4) (Han et al, 2013; Fusakio et al,
2016) which in turn activates the transcription of genes involved in the
integrated stress response (ISR) (Costa-Mattioli & Walter, 2020).
The ISR protects cells from amino acid deprivation, oxidative, mito-
chondrial stressor viral infections, and is also incorporatedasabranchof
the ER unfolded protein response (UPR) upon PERK-activation. The ISR
comprises a negative feedback loop that causes eIF2α dephosphoryla-
tion, through the induction of GADD34 (also known as PPP1R15a), a
phosphatase 1 (PP1c) co-factor (Novoa et al, 2001; Harding et al, 2009).
Dephosphorylation of p-eIF2α by GADD34/PP1c complexes, and
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associated protein synthesis restoration, signal ISR termination,
and return to cellular homeostasis (Novoa et al, 2001). If stress persists,
long-term ATF4 expression promotes programmed cell death, through
the induction of the pro-apoptotic transcription factor CHOP (Marciniak
et al, 2004). ATF4 also regulates the expression of Rho GTPases and can
control cell motility (Pasini et al, 2016), whereas globular actin is part of
the PP1c/GADD34 complex and provides additional targeting specificity
for dephosphorylating p-eIF2α (Chambers et al, 2015; Chen et al, 2015).
The ISR can enter in a cross talk with specialized MAMPs sensing
pathways,which turnsonoramplifies inflammatory cytokinesproduction
in different cell types including DCs (Claudio et al, 2013; Reverendo et al,
2018). TLR activation in macrophages undergoing an ISR suppress CHOP
induction and protein synthesis inhibition, preventing apoptosis in ac-
tivated cells (Woo et al, 2009). Moreover, ATF4 binds interferon regulatory
factor-7 (IRF7) and prevents type-I IFN transcription (Liang et al, 2011).
Several key innate immunity signaling cascades are also believed to be
dependent for their signalosome assembly on the chaperoneHSPB8 and
the eIF2α kinase heme-regulated inhibitor (HRI/EIF2AK1) (Pierre, 2019).
Microbe-activated HRI was shown to mediate phosphorylation of eIF2α
and increase ATF4-dependent expression of HSPB8, thus amplifying
signal transduction and inflammatory cytokines transcription in mac-
rophages (Abdel-Nour et al, 2019).
We show here that DCs from spleen or derived from Fms-related
tyrosine kinase 3 ligand (Flt3-L) treated-BM cultures display high levels
of phosphorylated eIF2α. Using Cre/lox recombination to generate
mice specifically lacking GADD34 (PPP1R15a) or PERK (EIF2AK3) activity
in DCs, wedemonstrate that PERK-dependent eIF2α phosphorylation is
acquired during BMDC differentiation in vitro. PERK drives high eIF2α
phosphorylation in steady-state DCs with a low impact on protein
synthesis levels. We found that mRNA translation in DCs, differently to
what has been shown during chronic ISR (cISR) (Guan et al, 2017), is
mediated despite high p-eIF2α levels by an eIF4F-dependent mech-
anism. These features endow DC with increased resistance to acute ER
stress, preventing ATF4 induction in response to stressors such as the
bacterial subtilase cytotoxin (SubAB). We also found that LPS-activated
primary DCs rely on PERK and eIF2α phosphorylation to amplify type-I
IFN expression, but, conversely to macrophages, not to promote pro-
inflammatory cytokines transcription nor IL-1β secretion (Abdel-Nour
et al, 2019; Chiritoiu et al, 2019). GADD34 antagonizes PERK activity to
maintain functional protein synthesis levels in non-activated DCs and
upon stimulation with LPS, contributing directly to DC function by
modulating IFN-β expression. PERK activity impacts positively DC
migration speed, correlating with the regulation of p-eIF2α levels by
the synergistic action of GADD34 and actin cytoskeleton reorganization.
Thus, DCs require PERK and GADD34 activity to coordinate protein
synthesis, activation, type-I IFN production and migration capacity in
response to MAMPs and adapt their biochemical functions to the
variations encountered in their external environment.
Results
Steady-state DCs display high levels of eIF2α phosphorylation
Physiological levels of phosphorylated eIF2α (p-eIF2α) were
monitored in mouse spleen sections by immunohistochemistry. All
CD11c+ DC subsets expressing either CD8α (cDC1), CD11b (cDC2), or
B220 (plasmacytoı̈d DC, pDC), displayed high levels of eIF2α
phosphorylation (Fig 1A and B), strongly contrasting with other
splenocytes, such as B cells (Fig 1B lower panel). Splenocytes
isolation and flow cytometry based-quantification of eIF2α phos-
phorylation confirmed that DC subsets display higher levels of
p-eIF2α than T (CD3+/CD4+ or /CD8+) or B cells (Fig 1C). We next
evaluated p-eIF2α in BM-derived DCs differentiated in presence of
Flt3-Ligand (Flt3-L BMDC), encompassing the major cDC1, cDC2, and
pDC subsets in different proportions (circa 30%, 60%, and 10%,
respectively) with phenotypes equivalent to those of spleen DC
subsets (Brasel et al, 2000). Cell sorting and analysis of the different
populations by immunoblot confirmed that all DC subsets display
higher eIF2α phosphorylation in comparison with isolated primary
CD8+ T cells or MEFs stimulated or not with the ER-stress inducing
drug thapsigargin for 2 h (Fig 1D). Quantification of p-eIF2α/eIF2α
ratios indicated that steady-state DCs display two to four times
more p-eIF2α, than stressed MEFs, with the cDC1 population dis-
playing the highest ratio of phosphorylation (Fig 1D). We next
evaluated when eIF2α phosphorylation was acquired during DC
differentiation in vitro. Daily analysis of differentiating Flt3-L BMDCs
established that high p-eIF2α levels appear from 4 d of culture (Fig
1E), confirming that eIF2α phosphorylation is an integral part of Flt3-L
induced DC differentiation.
Given the dominant negative effect of p-eIF2α on translation
initiation, we monitored protein synthesis in the different DC
subsets. CD8+ T cells were used as a reference because in these
cells, p-eIF2α is barely detectable. We used puromycilation and
detection by flow cytometry (flow) to measure protein synthesis
level in splenocytes populations (Schmidt et al, 2009; Arguello et al,
2018). Despite higher eIF2α phosphorylation levels in all resting DC
subsets, mRNA translation is five to eight times higher than in
resting CD8+ T cells and close to the levels reached by these cells
upon CD3/CD28 stimulation (Fig 1F). We next monitored protein
synthesis every 2 d of culture to establish precisely the influence of
eIF2α phosphorylation during DC differentiation in vitro. We applied
flow cytometry and dimensionality reduction using t-distributed
stochastic neighbor embedding (tSNE) to visualize DC differentia-
tion and protein synthesis activity within the different subpopu-
lations over time (Fig 2A). We confirmed that protein synthesis
levels steadily increased with the appearance of all three DC
subsets, this despite high eIF2α phosphorylation. Noteworthy, the
cDC1 population that displays the most elevated level of eIF2α
phosphorylation is the DC subset endowed with the highest level of
protein synthesis. These observations suggest that steady-state
DCs have adapted their translation machinery to overcome the
dominant negative effect on translation initiation of eIF2α phos-
phorylation on Ser51, which is associated with the acquisition of the
DC phenotype.
eIF2B and eIF2A expression is up-regulated upon DC
differentiation
P-eIF2α inhibits translation initiation by forming a stable inhibitory
complex that reduces the guanidine exchange factor activity of
eIF2B. eIF2B is an enzymatic complex with a γ2ε2 sub-units core with
levels generally lower than those of its substrate eIF2. Thus, a
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Figure 1. Steady-state Flt3-L BMDCs and splenic DCs display remarkably high levels of eIF2α without inhibition of translation.
(A) Immunohistochemistry of mouse spleen with staining for CD11c (red) and p-eIF2α (green). Scale bar: 200 μm, magnification: 10×. Single color images are shown and
merged picture (right row), high level of p-eIF2α staining is mostly found co-localizing in cells positive for CD11c+ (DCs, white arrowheads). (B) Immunohistochemistry of
mouse spleen in the white pulp for CD11c (red), p-eIF2α (green), CD11b (blue), and B220 (turquoise). Scale bars: 50 μm, magnification: 40×. In the upper panel, magnified
areas show p-eIF2 detection in cDC2 (CD11c+/CD11b+) and cDC1 (CD11c+/CD11b−). In the lower panel, magnified areas show p-eIF2 detection in pDCs (B220+/CD11c+) and
in B cells (B220+ and CD11c−). (C) Relative p-eIF2α levels measured by flow in different mouse spleen populations. Statistical analysis was performed by Mann–Whitney
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partial eIF2α phosphorylation is sufficient to attenuate protein
synthesis initiation in most cells (Adomavicius et al, 2019). We
monitored, during Flt3-L BMDC differentiation, the expression of
the different eIF2B components. From day 2 in culture, all eIF2B
subunits levels were increased transcriptionally, and for eIF2Bε,
translationally as well (Fig 2B and C). A similar observation was
done with eIF2A, a factor involved, in place of eIF2, in the translation
of specialized cellular or viral mRNAs (Kim et al, 2011; Starck et al,
2016). The progression of the ratio eIF2Bε, and potentially of eIF2A,
over eIF2α expression and phosphorylation during differentiation
(Fig 2C) could therefore explain the progressive acquisition by
BMDCs of significant protein synthesis levels despite abundant
eIF2α phosphorylation.
Flt3-L BMDCs activation by LPS promotes eIF2α and eEF2
dephosphorylation
Complementary to p-eIF2α, phosphorylated translation elongation
factor 2 (eEF2) is a major repressor of translation in adverse growth
conditions, such as starvation, or accumulation of misfolded
proteins in the ER (Ryazanov, 2002; Lazarus et al, 2017). Like for
p-eIF2α (Fig 3A), the high levels of p-eEF2 present in steady-state
DCs (Arguello et al, 2018) were gradually decreased during
Escherichia coli LPS stimulation of TLR4-expressing cDC2 (Fig 3B).
eEF2 phosphorylation therefore parallels what is observed for eIF2α
in cDC1 and cDC2 (Fig 3A) and could be involved in the control of
protein synthesis levels upon DC activation. Given the rapidity and
intensity of eIF2α and eEF2 dephosphorylation upon activation, we
applied to cDC2 the SunRISE technique, a method for monitoring
translation elongation intensity using flow (Arguello et al, 2018).
cDC2 displayed a striking augmentation of translation intensity
upon LPS activation compared with the steady-state situation (T = 0
s), quasi doubling its level in 6 h (Fig 3C and D). Polysomes elon-
gation speed, indicated by the rate of puromycin staining decay
after harringtonine treatment (slope), was also increased (x2) by
LPS (Fig 3D). eIF2α and eEF2 dephosphorylation are correlated with
increased mRNA translation initiation and elongation allowing
protein synthesis to reach its maximum concomitantly to the
acquisition by DC of their full immune-stimulatory capacities
(Lelouard et al, 2007).
PPP1R15a (GADD34) controls eIF2α dephosphorylation in
activated DCs
The inducible PP1c co-factor PPP1R15a, known as GADD34, is key in
mediating p-eIF2α dephosphorylation in the resolution phase of
the ISR during the UPR (Novoa et al, 2001, 2003). Interestingly,
GADD34 induction was reported in inflammatory situations or upon
MAMPs stimulation of different immune cell subsets (Clavarino
et al, 2012b, 2016; Ito et al, 2015). In MEF, GADD34 expression is
necessary for the production of IFN-β upon concomitant sensing of
cytosolic dsRNA by RIG I-like-helicases and activation of protein
kinase RNA-activated (PKR)-dependent phosphorylation of eIF2α
(Clavarino et al, 2012a).
To further explore the importance of GADD34 in the control eIF2α
pathway in DC, we generated a novel transgenic mouse model with
floxed alleles for Ppp1r15a/Gadd34. This modification in the
Ppp1r15a gene allows, upon Cre recombinase expression, the de-
letion of the third exon that codes for the C-terminal PP1 interacting
domain of GADD34. This deletion creates a null phenotype for
GADD34-dependent eIF2α dephosphorylation (Harding et al, 2009)
(Fig S1A). Ppp1r15aloxp/loxp C57/BL6 mouse was crossed with an
Itgax-cre deleter strain (Caton et al, 2007) to specifically inactivate
GADD34 activity in CD11c-expressing cells, including all DC subsets.
Despite inducing a light splenomegaly, GADD34 inactivation had no
obvious consequences for splenocyte development in vitro and
in vivo (Fig S2). Flt3-L BMDCs derived from WT and Itgax-cre/
Ppp1r15aloxp/loxp (GADD34ΔC) mice were LPS-activated prior de-
tection of different translation factors by immunoblot (Fig 4A).
GADD34 inactivation prevented LPS-dependent eIF2α dephos-
phorylation; however, phosphorylation levels of the activator β
subunit of eIF2 (eIF2β), eEF2, and ribosomal S6 protein remained
unchanged, underlining GADD34 specificity for eIF2α (Fig 4A). eIF2β
phosphorylation is known to counteract p-eIF2α negative effect and
promotes mRNA translation (Gandin et al, 2016). However, in our
experimental setting, it was neither impacted by LPS activation nor
by the loss of GADD34 activity. eIF2β is, therefore, unlikely to in-
terfere with eIF2α regulation in DCs. Functional deletion of GADD34
inhibited translation initiation in both steady-state and LPS-
activated cDC2 (Fig 4B), and also reduced translating polysomes
speed in non-stimulated cells. GADD34 expression seems, there-
fore, to prevent protein synthesis inhibition linked to abundant
eIF2α phosphorylation in steady-state DCs. The amount of eIF2B
present in the DC seems, however, sufficient tomaintain a lower but
still active protein synthesis despite GADD34 inactivation and in-
creased p-eIF2α (Fig 4A).
In MEF, whereas induction of GADD34 transcription during ER
stress is ATF4 dependent (Walter & Ron, 2011), expression of GADD34
upon viral sensors activation is interferon regulatory factor 3 (IRF3)
dependent (Dalet al, 2017). We, therefore, inhibited the TANK-
binding kinase 1 (TBK1)/IKKε/IRF3 signaling axis to investigate if
it is also responsible of GADD34 induction in LPS-activated DCs.
Treatment with the TBK1 inhibitor (MRT67307, TBKin) (Clark et al,
2011) prevented LPS-dependent induction of GADD34mRNA (Fig 4C).
Ppp1r15a/GADD34 transcription is, therefore, also partially de-
pendent on the TBK1/IKKε signaling cascade in DC and not only on
test. **P < 0.01. (D) Levels of p-eIF2α and total eIF2α were measured in DC populations by immunoblot. Sorted steady-state Flt3-L BMDCs were compared with MEFs and
freshly isolated CD8α+ T cells stimulated or not with thapsigargin (Tg) for 2 h (200 nM). Ratio of p-eIF2α/eIF2α is quantified in the graph of the lower panel. (E) Levels of
p-eIF2α and total eIF2α were measured in bulk Flt3-L BMDCs during different days of BM differentiation in vitro. (F) Levels of protein synthesis were measured by
puromycilation and intracellular flow cytometry detection in different subsets of Flt3-L BMDCs and in CD8+ splenic T cells. Cells were incubated with puromycin 10 min
before harvesting and when indicated, cycloheximide (CHX, 10 μM) was added 5 min before puromycin. Steady-state Flt3-L BMDCs were directly compared with CD8+
splenic T cells either steady-state or stimulated overnight with anti-CD3 (10 μg/ml) and anti CD28 (5 μg/ml). Samples without previous incorporation of puromycin were
used as control. All data are representative of n = 3 independent experiments. Data in (F) represent mean fluorescence intensity ± SD of three independent experiments.
Statistical analysis was performed using unpaired t test (****P < 0.0001).
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the ATF4-dependent transcriptional axis. Importantly, protein
synthesis was reduced in GADD34ΔC cells (Fig 4B) and eIF2α
phosphorylation increased upon TBK1 inhibition in resting cells (Fig
4D). However, GADD34 mRNA expression levels were too low to
define if basal IKKε/TBK1/IRF3 signaling activity could promote
GADD34 mRNA expression in steady-state BMDCs. These results
suggest nevertheless that GADD34 transcription and translation is
regulated in both steady-state and activated DCs by the IKKε/TBK1/
IRF3 signaling cascade (Reid et al, 2016).
PERK mediates eIF2α phosphorylation in steady-state DCs
We next investigated the consequences of inactivating known
eIF2α kinases in steady-state Flt3-L BMDCs (Krishna & Kumar,
2018). We tested pharmacological and genetic inactivation of
PKR (EIF2AK2) and GCN2 (EIF2AK4) (Fig S3), without observing any
major disturbances in eIF2α phosphorylation levels. We next
turned toward the ER-stress kinase PERK (EIF2AK3) by crossing
PERKloxp/loxp mice with the Itgax-cre strain (Caton et al, 2007)
allowing for the deletion of the exons 7–9, coding for the kinase
domain (PERKΔK) in most CD11c-expressing cells (Fig S1B). PERK
protein synthesis levels were enriched in WT CD11c+ splenic DC
compared with other splenocytes (Fig 5A). PERK expression was
efficiently abrogated in Flt3-L BMDCs and to a relatively lesser
extent in spleen DCs isolated from animals bearing the floxed-
PERK alleles (Fig 5A). PERK inactivation did not impair DC devel-
opment in vitro nor in vivo (Fig S4) but decreased p-eIF2α levels by
60% in steady-state DCs (Fig 5B), whereas p-eEF2 levels remained
unchanged (Fig 5C). Interestingly, LPS stimulation induced eIF2α
dephosphorylation although PERK levels were increased upon
activation of WT Flt3-L BMDCs (Figs 4A and 5A). PERKΔK DCs did not
display any additional decrease in p-eIF2α levels, suggesting that
GADD34/PP1c activity requires functional PERK activity or high
p-eIF2α levels to be implemented in DCs. Conversely to GADD34-
deficient cells, PERK deletion increased translation initiation and
elongation rate as measured by SunRISE in both steady-state and
LPS stimulated cDC2 (Fig 5D). PERK is the EIF2AK responsible for
most eIF2α phosphorylation in Flt3-L BMDCs DCs and mirrors
GADD34 activity to regulate active protein synthesis at steady-
state and during DC activation.
DCs are insensitive to ISR induction by subtilase cytotoxin
(SubAB)
PERK is activated during DC development leading to intense eIF2α
phosphorylation at steady state, whereas these cells avoid
translational arrest, by expressing GADD34 and eIF2B, among other
potential compensatory biochemical mechanisms. We initiated a
search to identify the cause of PERK activation in DCs by testing if ER
stress triggers IRE1α and PERK activation during DC differentiation.
We monitored the splicing of XBP1 mRNA that reflects IRE1α
pathway activation (Walter & Ron, 2011) and found limited accu-
mulation of the spliced form of the XBP1mRNA (sXBP1) in the bulk of
differentiating DCs (Fig S5A). mRNA expression of other major
transcription factors induced during the UPR (Walter & Ron, 2011;
Han et al, 2013), such as ATF4 and ATF6, was found moderately
increased at day 7, whereas CHOP transcription remained
unaffected during differentiation. Because the induction of these
factors is mostly regulated at the posttranscriptional level, we
wondered if the constant PERK activity observed in DCs could in-
duce a chronic ATF4-dependent ISR in these cells. Recently,
translational and transcriptional programs that allow adaptation to
chronic ER stress have been described by Guan et al (2017). This cISR
operates via PERK-dependent mechanisms, which allow simulta-
neous activation of stress-sensing and adaptive responses while
allowing recovery of protein synthesis.
We took advantage of available transcriptomic data (GSE9810,
GSE2389) and of ATF4/CHOP-dependent gene (Han et al, 2013) to
perform a Gene Set Enrichment Analysis (GSEA) and define the
level of common gene expression found in DCs and potentially
shared with an artificially induced acute or cISR. GSEA was fol-
lowed by multiple testing correction (Subramanian et al, 2005)
using the BubbleGUM software, which allows statistical assess-
ment and visualization of changes in the expression of a pre-
defined set of genes in different conditions (Spinelli et al, 2015).
GSEA revealed no significant enrichment of ATF4- and CHOP-
dependent genes expression in the DC transcriptome (false
discovery rate [FDR] > 0.25) (Fig S6A and B). Acute ISR- and cISR-
dependent transcriptions, respectively, obtained after 1- or 16-h
treatments with thapsigargin (Guan et al, 2017) were also com-
pared with splenocyte transcriptomes. Again, no significant gene
enrichment could be detected during these analyses (Fig S6C and
D) (FDR > 0.25).
PERK- and p-eIF2α-mediated translational reprogramming
during cISR appears to bypass cap-mediated translation (Guan
et al, 2017). We, therefore, tested if protein synthesis in Flt3-L
BMDC was independent of 59 mRNA cap binding eIF4F complex,
composed of eIF4A, eIF4E, and eIF4G. We used 4EGI-1, an inhibitor of
eIF4F assembly (Moerke et al, 2007), and ROCA, an eIF4A inhibitor
(Iwasaki et al, 2019), to treat WT and PERK-deficient DCs and confirm
the dependency of their protein synthesis on eIF4F activity. Both
compounds had a profound inhibitory effect on DCs translational
activity (80% of reduction), irrespective of their subsets or acti-
vation state (Fig S5B and C). This level of inhibition indicates that DC
mostly depend on eIF4F-dependent cap-mediated translation, thus
again contrasting from cells undergoing cISR (Guan et al, 2017). DCs
have therefore adapted to the consequences of high eIF2α
phosphorylation to allow for translation of their specialized
transcriptome, without induction of acute or cISR and ATF4-
dependent transcriptional programs.
The lack of ATF4-dependent gene signatures in DCs when
compared with other CD45+ cell types made us to wonder whether
the high p-eIF2α levels observed at steady state could interfere
with DC capacity to respond to ER-stress. ER-chaperone BiP
(HSPA5, heat shock protein family A (Hsp70) member 5) is a key
component of the UPR. Accumulation of misfolded protein in the
ER-lumen causes BiP dissociation from IRE1α and PERK to induce
their dimerization and initiate the different signaling cascades
controlling the UPR. Flt3-L BMDCs were exposed to subtilase
cytotoxin (SubAB), a bacterial AB5 toxin, which by proteolytic
cleavage of BiP induces a strong UPR, including PERK-dependent
eIF2α phosphorylation (Paton et al, 2006). When WT and PERKΔK
DCs were submitted to SubAB treatment, a modest PERK-
dependent phosphorylation of eIF2α was observed in WT cells
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Figure 2. Protein synthesis is increased during in BMDCs differentiation.
(A) Levels of protein synthesis weremeasured every 2 d by flow cytometry during Flt3-L BMDCs differentiation in vitro (0, 2, 4, and 7 d). Cells were incubated during 10min
with puromycin, intracellularly stained with an α-puromycin antibody prior analysis. The same dimensionality reduction using t-distributed stochastic neighbor
embeding was applied to all samples. Macrophages (Macs) in black are gated as CD45+, CD11c+, CD11b+, F4/80+, and CD64+ cells; cDC1 in red express CD45+, CD11c+, MCHII+,
and CD24+; cDC2 in purple express CD45+, CD11c+, MHC II+, CD11b+, and Sirpα+; pDC in yellow express CD11cint and Siglec H+; cells negative for CD45 in gray are considered
as non-immune. (B) mRNA levels of eIF2Bε (Β5); eIF2Bγ (Β3), eIF2Bα (Β1), eIF2Bβ (Β2), eIF2Bδ (Β4), eIF2α (eIF2S1), and eIF2A measured by qRT-PCR in bulk Flt3-L BMDCs at
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(Fig 6A), with limited consequences on translation (Fig 6B). In
contrast to SubAB, thapsigargin treatment arrested translation
more efficiently and triggered stronger eIF2α phosphorylation by
PERK, but also by a different EIF2AK because p-eIF2α levels were
also increased in PERKΔK cells. Little ATF4 could be detected in the
cytosolic or nuclear fractions of control or toxin-treated DC (Fig 6C),
reflecting the modest induction of eIF2α phosphorylation (Fig 6D),
and confirming the limited impact of SubAB on ISR induction. The
efficacy of SubAB treatment was tested in MEFs, in which ATF4 was
strongly induced by the toxin and absent from control ATF4−/−
cell (Fig 6C). DCs are therefore unable to induce the ISR upon
SubAB treatment, despite the activation of other UPR branches, as
demonstrated by augmented IRE1α activity (Fig 6E), that is re-
sponsible for XBP-1 splicing and translation reduction through
IRE1-dependent decay of mRNA (RIDD) (Tavernier et al, 2017). BiP
mRNA levels were moderately augmented during DC differenti-
ation. However, the similar expression levels observed for DCs and
MEFs (Fig 6F) suggest that BiP transcriptional regulation is not
involved in the DC resistance to SubAB. The relatively high PERK
and GADD34 activity observed in steady-state DCs, together with
indicated days of differentiation and compared with control MEFs. (C) Levels of eIF2Bε, P-eIF2α, total eIF2α, and β-actin weremeasured in bulk Flt3-L BMDCs at indicated
days of differentiation in vitro. Quantification of the ratio eIF2Bε/P-eIF2α is shown on the right. All data are representative of n = 3 independent experiments. Data in (B)
represent Mean ± SD of three independent experiments. Statistical analysis was performed using Dunnett’s multiple comparison (*P < 0.05, **P < 0.01, and ***P < 0.001).
Figure 3. P-eIF2α and p-eEF2 levels are down-regulated upon LPS stimulation.
Flt3-L BMDCs were stimulated with LPS (100 ng/ml) for indicated hours. (A, B) Monitoring of p-eIF2α and (B) p-eEF2 by intracellular flow in CDC1 and cDC2. (C) Flow
detection of puromycin incorporation was performed on the cDC2 population. Total puromycinmean fluorescence intensity between steady-state and LPS activated cDC2
is shown for different time of harringtonine treatment. (D)Mean fluorescence intensity was plotted as a decay slope and establish the speed of translation elongation. All
data are representative of n = 3 independent experiments. Data represent mean ± SD of three independent experiments. (A, B, C, D) Statistical analysis was performed
using Dunnett’s multiple comparison (A, B, C, D) Mann–Whitney test (**P < 0.01 and ****P < 0.0001).
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Figure 4. GADD34 mediates eIF2α dephosphorylation and controls translation in DCs.
WT and GADD34ΔC BMDCs were stimulated with LPS (100 ng/ml) for the indicated times. (A) Levels of p-eIF2α, total eIF2α, p-eIF2β, total eIF2β, p-eEF2, total eEF2, P-S6,
and total S6 were detected by immunoblot (top left) and quantification is shown in the different panels. (B) The speed of translation elongation wasmeasured by SunRISE
after 3 h of incubation with LPS. Harringtonine (2 μg/ml) was added at different times up to 90 s prior incubation with puromycin during 10 min. Flow intracellular staining
was performed in cDC2 using an α-puromycin antibody. The total decay of puromycinmean fluorescence intensity between WT and GADD34ΔC in steady-state and upon
activation indicates that translation initiation and elongation speed is decreased in GADD34-deficient DCs. Flt3-L BMDCs were pretreated with 2 μM of the TBK1 inhibitor
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high eIF2B expression, and potentially eIF2A, would prevent a full
ISR induction, including translation arrest, ATF4 synthesis and
associated transcriptional response.
Importance of the ISR for PRRs signaling
In macrophages, p-eIF2α- and ATF4-dependent expression of HSPB8
is required for the assembly of PRR signaling adapters, such as
mitochondrial antiviral-signaling protein (MAVS), or TIR domain–
containing adapter protein inducing interferon-α (TRIF), but not of
myeloid differentiation primary response gene 88 (MyD88). HSPB8
seems necessary for TRIF and MAVS to be incorporated into protein
aggregates that constitute signalosomes for different innate im-
munity signaling pathways triggered by MAMPs (Abdel-Nour et al,
2019). Given the lack of ATF4 synthesis and the resistance of active
DCs to mount an acute ISR, we investigated their capacity to produce
pro-inflammatory cytokines and type-I IFN in a perturbed eIF2α-
phosphorylation context. Importantly, we have previously shown that
GADD34-deficient BM-derived and spleen DCs, have a reduced ca-
pacity to produce IFN-β (Clavarino et al, 2012b; Perego et al, 2018). IFN-β
and IL-6 mRNA expression were therefore quantified after 4 h of LPS
activation of WT and PERKΔK DCs. IL-6 transcription (Fig S7A) and
secretion (Fig 7A) remained unchanged. However, IFN-β secretion
was reduced by half in PERKΔK DCs (Fig 7A), whereas its tran-
scription remained surprisingly unaffected in mutant cells (Fig S7A),
suggesting that PERK activity is necessary for normal synthesis and
secretion of IFN-β independently of the activation of the TRIF-
dependent pathway downstream of TLR4.
We further investigated the importance of eIF2α-phosphoryla-
tion with respect to PERK activity using a pharmacological ISR
inhibitor (ISRIB) (Sidrauski et al, 2015), which prevents inhibition of
eIF2B by p-eIF2α and prevents translation inhibition, as shown here
for MEFs in different ISR-inducing conditions (Fig 7B). ISRIB should
prevent the induction of the ISR in activated DCs and interfere, as
reported for macrophages (Abdel-Nour et al, 2019), with TRIF sig-
naling and down-stream IFN-β expression. In our experimental
system, we used LPS and polyinosinic:polycytidylic acid (poly(I:C)) to
stimulate, respectively, TRIF-dependent TLR4 and TLR3 (Fitzgerald &
Kagan, 2020). IFN-β mRNA induction upon stimulation of DCs with
either LPS (Figs 7C and S7B) or poly(I:C) (Fig S7B) was not impaired by
ISRIB. IL-6 transcription which is believed to be mostly Myd88-
dependent was moderately decreased by ISRIB in LPS-activated
DCs and more acutely in BMDM (Fig S7B and C), confirming that cell-
specific mechanisms control the transcription of the IL-6 family of
cytokines during the ISR (Sanchez et al, 2019). Importantly, TRIF-
dependent expression of IFN-β upon LPS activation of BMDM was
not impacted by ISRIB treatment, whereas comparatively, poly I:C
activation of these cells was too inefficient to obtain statistically
reliable data (Fig S7C). We next tested if ISRIB treatment augments
IFN-β, IL-6, IL-10, and TNF secretion after 4 h of LPS stimulation in
BMDM (Fig 7D). This unchanged (DC) or augmented (BMDM) IFN-β
production observed in the presence of ISRIB confirms that TRIF-
dependent signaling does not require acute ISR induction nor ATF4-
dependent transcription to promote signalosomes assembly and
cytokines expression in DC and probably also macrophages. ISRIB
facilitates, however, the production of several cytokines upon acti-
vation, confirming that eIF2α phosphorylation decreases the efficacy
of cytokines mRNAs translation upon MAMPs detection.
Given the impact of ISRIB on cytokine secretion, we decided to
analyze further the response to LPS in cells inactivated for PERK
pharmacologically. Cytokines expression was monitored in LPS-
activated DCs in presence of the PERK inhibitor GSK2656157 (Axten
et al, 2013) (Fig 7C). GSK2656157 treatment decreased both IFN-β and
IL-6 secretion by 30–50% (Fig 7A). Over 4 h of treatment, no significant
changes in IL-6 mRNA expression was observed, whereas IFN-β
transcription was reduced (Fig S7D). These cytokines seem therefore
differently affected by alterations in DCs of PERK activity and of eIF2α
phosphorylation. IL-6 transcription is sensitive to ISRIB and requires
eIF2α phosphorylation. IFN-β transcription and secretion seems,
however, dependent on PERK activity, but surprisingly not on eIF2α
phosphorylation nor the ISR. We extended our analysis to IL-10 and
TNF secretion upon GSK2656157 treatment of LPS-stimulated Flt3L-
BMDCs (Fig 8A). These cytokines expression remained, however,
unaffected by ISRIB, but like for IFN-β and IL-6, their translation was
reduced upon PERK inhibition, suggesting a key role for PERK in
promoting cytokines translation in activated DCs.
PERK was recently proposed to control the caspase-1–
dependent proteolysis of pro- to mature IL-1β to allow its secretion
(Chiritoiu et al, 2019). Given the contrasting effects of PERK inac-
tivation on IFN-β and IL-6 expression, we examined how WT and
PERKΔK-DCs co-stimulated with LPS and ATP were promoting the
conversion and secretion of mature IL-1β (Fig 8B). Surprisingly, we
did not observe any impairment of IL-1β expression in PERKΔK-DCs,
but rather an increase by 25% of both IL-1βmRNA transcription and
mature IL-1β secretion compared with WT cells (Fig 8B). IL-1β se-
cretion was also monitored in presence of ISRIB and GSK2656157
(Fig 8C), whichmoderately reduced IL-1βmRNA transcription only in
LPS and ATP activating conditions, this without incidence onmature
IL-1β secretion. These results suggest that acute pharmacological
PERK inactivation has little effect on IL-1β processing and secretion,
whereas long-term inactivation favors this secretion potentially by
decreasing the inflammasome activation threshold, as previously
observed in autophagy deficient macrophages or DCs (Terawaki
et al, 2015). PERK inactivation in DCs is therefore not detrimental to
IL-1β processing but favors its production and secretion, which
could in turn increase IL1B mRNA transcription in a feed-back
positive loop (Ceppi et al, 2009).
Antigen presentation in PERK-deficient DCs
Given the impact of PERK inactivation in DC capacity to secrete type-I
IFN, we decided to investigate how it could also interfere with the
(MRT67307) for 1 h, before stimulation with LPS (100 ng/ml) for indicated times. (C) mRNA levels of GADD34 were measured by qRT-PCR and normalized to the
housekeeping gene (GAPDH) level. (D) Immunoblot detection of p-eIF2α, total eIF2α, P-IRF3, and total IRF3. Quantification is represented on the right. (A, B, C) Statistical
analysis was performed using the Wilcoxon test (A, C, B), and Mann–Whitney test (*P < 0.05 and ****P < 0.0001). (D) All data are representative of n = 3 independent
experiments except (D), n = 2.
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Figure 5. PERK is activated in steady-state DCs.
(A) Immunoblot detection of PERK and β-actin. Quantification is shown on the right. WT and PERKΔK Flt3-L BMDC treated or not with LPS (100 ng/ml) for 6 h were compared
with CD11c+ and CD11c− fractions of splenocytes. WT and PERK−/−MEFs were used as control. (B, C)WT and Flt3-L PERKΔK BMDCs were stimulated or not with LPS (100 ng/ml)
for 4 h. (B) Quantification of p-eIF2α/eIF2α ratio (immunoblot). (C) Quantification of p-eEF2/eEF2 ratio (immunoblot). (D) The speed of translation elongation was measured
using SunRISE in Flt3-L cDC2 after 4 h of incubation with LPS. The total decay of puromycin mean fluorescence intensity between WT and PERKΔK in steady-state and upon
activation is showed. All data are representative of n = 3 independent experiments. (B, C, D) Statistical analysis was performed using Wilcoxon test (B, C) and Mann–Whitney
test (D). Data in (D) represent mean fluorescence intensity ± SD of three independent experiments (**P < 0.01, ***P < 0.001, and ****P < 0.0001).
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processing and presentation of exogenous antigens. Surface levels of
MHC II and CD86 of WT and PERKΔK BMDC were monitored by flow to
establish the capacity of DC1 and DC2 subsets to activate in response
to LPS (Fig S8A). Our analysis indicated that WT and PERKΔK BMDC
responded equally well to LPS stimulation and did not display
differences in surface MHC II nor CD86 levels that could suggest an
impairment in their presentation capacity to T cells. We next
incubated Flt3-L BMDCs for 8 h with increasing concentrations of
hen egg lysozyme (HEL) in presence or not of the PERK inhibitor
GSK2656157, prior assaying processing and presentation by
measuring CD69 surface up-regulation and the production of IL-2
by the 3A9 (HEL 48-62 on I-Ak) specific T hybridoma (Fig S8B). We
found that PERK inhibition had no effect on the efficiency of MHC II
restricted processing and presentation of soluble antigens in vitro
and consequently did not interfere with the transport of MHC II
molecules.
PERK and actin polymerization coordinates p-eIF2α levels and
migration in DCs
Recently, the importance of globular actin in the formation of a
tripartite holophosphatase complex assembled with GADD34 and
PP1c to dephosphorylate eIF2α was revealed (Chambers et al, 2015;
Crespillo-Casado et al, 2017, 2018). Given the unusual regulation of
eIF2α phosphorylation in DCs, actin organization could impact this
pathway in a different setting than artificial ER stress induction.
Actin depolymerizing and polymerizing drugs, respectively,
Latrunculin A (Lat A) and Jasplakinoloide (Jaspk) had opposite
effects on eIF2α phosphorylation in Flt3-L BMDCs (Fig 9A). globu-
lar actin accumulation induced by Lat A was strongly correlated
with eIF2α dephosphorylation (Fig 9A and B), whereas actin poly-
merization induced by Jaspk resulted in a massive increase in eIF2α
phosphorylation, together with a reduction in protein synthesis (Fig
9A and C). We next tested the impact of the two drugs on WT and
PERKΔK Flt3-L BMDCs activated or not by LPS (Fig 9D). LPS activation
or Lat A treatment resulted in the same levels of eIF2α dephos-
phorylation (Fig 9D). In contrast, Jaspk dominated LPS effect and
strongly increased p-eIF2α levels in all conditions tested. PERK
inactivation decreased the levels of p-eIF2α, but had no obvious
consequences on the efficacy of the drugs because both induced
similar responses in WT and PERKΔK cells.
We tested the impact of actin remodeling and translation reg-
ulation on the acquisition by DC of their immune-stimulatory
phenotypes. Surface MHC II and co-stimulatory molecule CD86
expression were up-regulated by LPS stimulation but remained
unaffected by Jaspk treatment (Fig S9A). Similarly, transcription
levels of key cytokines such as IL-6 and IFN-β were insensitive to
this actin polymerizing drug (Fig S9B and C). However, whereas IL-6
secretion remained identical, IFN-β levels were found reduced by
Jaspk treatment, as expected from a situation in which GADD34
activity is reduced (Clavarino et al, 2012b). Interestingly, the IL-6
gene was described to bear an upstream uORF-dependent
translational regulation, which could allow IL-6 mRNA translation
upon high eIF2α-phosphorylation conditions induced by Jaspk
treatment (Sanchez et al, 2019). Taken together, these observations
suggest that extensive actin polymerization in DCs increases
strongly eIF2α phosphorylation, affecting protein synthesis and
ultimately controlling translationally specific cytokines expression,
similarly to what has been observed with Cdc42 or Wiskott–Aldrich
syndrome protein mutants (Pulecio et al, 2010; Prete et al, 2013).
These results further suggest that actin dynamics and its effect on
eIF2α phosphorylation could be key regulating factors for the
homeostasis and translation of specific mRNA encoding for pro-
teins generally secreted in a polarized fashion, such as type I IFNs,
or associated with cell migration (Pulecio et al, 2010; Prete et al,
2013). Finally, given the interplay between eIF2α phosphorylation
and actin polymerization, we wondered whether PERK-deficient
cells could display some migratory deficits. We used micro-
fabricated channels, which mimic the confined geometry of the
interstitial space in tissues (Heuze et al, 2013; Bretou et al, 2017), to
find that PERK-deficient cells were not able to increase their mi-
gration speed in response to LPS (Fig 9E), confirming the link be-
tween eIF2α phosphorylation and actin dynamics. PERK activity is,
therefore, necessary for DCs to acquire normal immune-stimulatory
and migratory activities, presumably by coordinating protein syn-
thesis and translation specific mRNAs with actin polymerization.
Discussion
We have previously proposed the existence of a strong causative
link between cell activation by TLR ligands and eIF2α phosphory-
lation, notably by virtue of strong GADD34 expression in most
transcriptomics studies performed on PAMP-activated DCs
(Clavarino et al, 2012b; Claudio et al, 2013; Reverendo et al, 2018). Our
present work suggests that steady-state DCs activate PERK-
mediated eIF2α phosphorylation to acquire their functional
properties during differentiation (Fig S8), but distinctly from known
ISR programs, normally induced upon acute or chronic ER stress
(Han et al, 2013; Guan et al, 2017).
To our knowledge, the level of p-eIF2α observed in primary DC
both in vivo and in vitro are unique in their amplitude. Although as
judged comparatively from experiments performed with artificial
induction of the different EIF2KAs, such p-eIF2α levels should be
inhibitory for global protein synthesis (Dalet et al, 2017). DCs have
acquired biochemical resistance, like high expression of eIF2B and
eIF2A, to compensate for the consequences of this developmental
PERK activation and to undergo high eIF2α phosphorylation,
whereas maintaining normal proteostasis.
ATF4’s role in controlling Ppp1r15a/GADD34 mRNA expression
and eIF2α dephosphorylation to restore protein synthesis during
stress has been extensively studied (Novoa et al, 2001). Despite high
eIF2α phosphorylation, the active translation observed in DCs does
not seem to allow ATF4 synthesis and consequently the activation
of a bona fide ISR in these cells. In contrast, GADD34 is functional in
non-activated DCs with IKKε/TBK1 activity required for its mRNA
transcription. This dependency of Ppp1r15a/GADD34 transcription
on IKKε/TBK1 confirms that the PPP1R15a gene belongs to a group of
genes directly induced by TLR or RLR signaling, as previously
suggested by genomic analysis of viral or poly (I:C)-stimulated cells
(Freaney et al, 2013; Lazear et al, 2013; Dalet et al, 2017). GADD34
protein expression is undetectable in DCs, without prior treatment
with proteasome inhibitors (Clavarino et al, 2012b), which is
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Figure 6. Flt3-L BMDCs are resistant to subtilase cytotoxin-induced integrated stress response.
WT and PERKΔK Flt3-L BMDCs were stimulated with thapsigargin (200 nM) and subtilase cytotoxin (SubAB, 250 ng/ml) for the indicated times. (A) Levels of p-eIF2α and
total eIF2α detected by immunoblot (left) and quantified (right). (B) Levels of protein synthesis measured by flow using puromycilation detection in cDC2. Cells were
incubated with puromycin 10 min before harvesting. The graph shows the total puromycin mean fluorescence intensity levels. (C) WT Flt3-L BMDCs, WT and ATF4−/− MEFs
were stimulatedwith subtilase cytotoxin (SubAB, 250 ng/ml) for 2 h. Both cytoplasmic (cyt) and nuclear (nuc) fractions were analyzed. Levels of p-eIF2α, total eIF2α, ATF4,
and HDAC1 (nuclear loading control) were revealed by immunoblot. (D) p-eIF2α quantification is represented in (D). (E) WT Flt3-L BMDCs were stimulated with subtilase
cytotoxin (SubAB, 250 ng/ml) for the indicated times. mRNA levels of spliced XBP1 were measured by qRT-PCR in bulk Flt3-L BMDCs. Raw data were normalized to total XBP1
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presumably indicative of an extremely fragile equilibriumbetween its
translation and active degradation. GADD34 mRNA translation, like
that of ATF4, is controlled through 59 upstream ORFs regulation,
which are normally bypassed upon general translation arrest to favor
the synthesis of these specific ISR molecules (Palam et al, 2011).
Interestingly, GADD34 mRNA has been recently shown to be also
actively translated in unstressed MEFs, albeit at much lower levels
than upon ER stress (Reid et al, 2016). Thus, in steady-state DCs,
GADD34 synthesis likely occurs in a high eIF2α-phosphorylation
context, despite relatively normal level of translation, whereas that of
ATF4 does not. The difference in the 59 upstreamORFs organization of
themRNAs coding for these twomolecules (Palamet al, 2011; Andreev
et al, 2015), could explain this difference, and how GADD34/PP1c
activity contributes to the maintenance of protein synthesis activity
by counteracting PERK in steady-state DCs.
Importantly, the PERK/eIF2α/GADD34 molecular trio sets the
physiological range for potential protein synthesis initiation available
in the different DC activation stage; however, the upward progression
triggered by LPS stimulation, from one level of protein synthesis to the
next, does not depend on this biochemical axis and is likely regulated
by other protein synthesis regulation pathways, like the mTORC1 or
casein kinase 2 pathways (Lelouard et al, 2007; Reverendo et al, 2019)
(Fig S10). Other mechanisms that contribute to escape PERK-mediated
eIF2α phosphorylation, including the eIF2B-independent and eIF3-
dependent pathway recently described to rescue translation during
chronic ER stress (Guan et al, 2017), do not seem to be used in the DC
context. Given the amount of eIF2A and eIF2B expressed by differ-
entiated DCs, these factors are likely to be sufficient to counteract
excessive eIF2α phosphorylation and maintain protein synthesis level
in DCs. This activity could be equivalent to the TLR-dependent acti-
vation of eIF2B through PP2A-mediated dephosphorylation of the
eIF2Bε-subunit, which prevents translation arrest in tunicamycin
treated macrophages (Woo et al, 2012).
These DC-specific mechanisms prevent the induction of the ISR
by the AB5 subtilase cytotoxin, which targets the ER chaperone BiP.
Independently of demonstrating that induction of acute eIF2α
phosphorylation by thapsigargin is not solely dependent on PERK
activation, our observations suggest that DCs could escape EIF2KA-
dependent translation arrest during exposure to different meta-
bolic insults relevant to the immune context. These situations can
include viral infection (Clavarino et al, 2012b), exposure to high
levels of fatty acids during pathogenesis, oxidative stress during
inflammation or amino acids starvation, mediated by amino
acid–degrading enzymes, such as arginase 1 or IDO, which are
induced during infection or cancer development (Munn et al, 2004;
Claudio et al, 2013). Importantly we could also show, which the ISR
induction is not necessary for DCs to drive the transcription of pro-
inflammatory cytokines in response to TRIF or MAVs dependent-
signaling (Abdel-Nour et al, 2019), nor the secretion of IL-1β
(Chiritoiu et al, 2019).
PERK activation is therefore required to regulate mRNA trans-
lation during DC differentiation and potentially also GADD34 syn-
thesis, which not only provides a negative feed-back to PERK, but
also is required for normal DC activation and cytokines expression
(Clavarino et al, 2012b; Perego et al, 2018). Although a role for the ISR
has been suggested to favor the survival of tissue associated DCs
(Tavernier et al, 2017), we could not detect any particular phenotype
impairing the development of DCs in the spleen of PERK-deficient
animals. A close examination of the functional capacity of DC in
vitro showed that although soluble antigen presentation was not
affected by PERK inactivation, it induced nevertheless an alteration
of IFN-β and cytokines production as well as of DC migratory ca-
pacity upon MAMPs activation. Interestingly, ROCK-induced acto-
myosin contractility in transformed fibroblasts enhances signaling
through PERK and ATF4 (Boyle et al, 2020), whereas PERK itself has
been shown to interact with filamin-A and to participate to F-Actin
remodeling in MEFs (van Vliet et al, 2017), suggesting that the mi-
gratory deficit observed in PERK-deficient DCs could be also de-
pendent on these interactions. This finding echoes with the
existence of a cross-talk between actin skeleton organization and
the main molecular actors involved in the ISR (Chambers et al, 2015;
Chen et al, 2015). We confirmed that globular actin synergizes with
the PP1c to dephosphorylate p-eIF2α, suggesting that the PERK/
GADD34 pathway could play an important role in regulating
translation in response to actin dynamics and possibly in coor-
dinating migration or interactions with T cells.
DCs therefore represent a model of choice for studying this
possibility, given their developmental regulation of eIF2α phos-
phorylation and their requirement for actin dependent-
phagocytosis and migration to perform their immune-stimulatory
function. The activation of PERK/GADD34 pathway in steady-state
DCs also underlines the importance of these molecules in ho-
meostatic condition, independently of obvious acute ER stress, for
the acquisition of specialized function. Clearly, the use of PERK-
deficient cells versus pharmacological inhibition creates some
discrepancies on how several biochemical functions in DCs are truly
affected directly by PERK loss or reduced eIF2α phosphorylation.
Our findings open nevertheless new pharmacological perspectives




BM was collected from 6- to 9-wk-old female mice and differen-
tiated in DCs or macrophages during 7 d. The culture was kept at
37°C, with 5% CO2 in Roswell Park Memorial Institutemedium (RPMI)
(GIBCO), 10% FCS (Sigma-Aldrich), 100 U/ml penicillin, 100 U/ml
streptomycin (GIBCO), and 50 μM β-mercaptoethanol (VWR) sup-
plemented with Flt3-L, produced using B16-Flt3-L hybridoma cells
for DC differentiation or M-CSF for macrophages, as described
previously (Wang et al, 2013). For the migration assays, GM-CSF was
used instead of Flt3-L and cells were cultured during 10–12 d with
mRNA expression. (F) Levels of BiP mRNA expression measured by qRT-PCR during Flt3-L BMDCs differentiation and in MEFs stimulated with thapsigargin for 30 min.
Data are mean ± SD (n = 3). Statistical analysis was performed using Dunnett’s multiple comparison (*P < 0.05 and **P < 0.01).
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changes in the medium each 3 d. GM-CSF was obtained from
transfected J558 cells (Pierre et al, 1997). To obtain splenocytes,
spleens were collected and injected with Liberase TL (Roche) and
incubated 25 min at 37°C to disrupt the tissues. DC purification was
performed using a CD11c+ positive selection kit (Miltenyi), according
to the manufacturer’s instructions and CD8α+ T-cell isolation was
performed with a Dynabeads untouched mouse CD8 T cells kit from
Thermo Fisher Scientific. CD8α+ T where incubate overnight with anti-
CD3 (10 μg/ml) and anti-CD28 (5 μg/ml) antibodies, to mimic acti-
vation by APCs. MEFs used in this work, ATF4−/− andmatchedWT (129
SvEv) were a kind gift from Prof. David Ron (Cambridge Institute for
Medical Research). PERK KO−/− and matched WT were a kind gift from
Prof. Douglas Cavener (Penn State University). MEFs were cultured
in DMEM medium (GIBCO) with 5% FBS (Sigma-Aldrich) and 50 μM
2-mercaptoethanol. For the experimental assays, cells were plated
from 16 to 24 h before stimulation in six well plates, at 150,000 cells/ml
in 2 ml of the same medium. After stimuli, cells were treated with
trypsin–EDTA for 2 min at 37°C before washing to detach cells from the
wells.
Reagents
LPS (E. coli O55:B5), cycloheximide, puromycin, MRT67307,
GSK2656157, rocaglamide, and thapsigargin were purchased from
Sigma-Aldrich. Harringtonine is from ABCAM, Latrunculin A, and
Jasplakinolide are from Merck-Millipore. Low molecular weight
polyinosinic-polycytidylic acid (LMW poly(I:C)) was from InvivoGen.
SAR1 was kindly provided by Sanofi and Integrated Stress Response
Inhibitor (ISRIB) was a gift from Carmela Sidrausky and Peter Walter
(UCSF). Subtilase cytotoxin (Shiga toxigenic E. coli strains) was
purified from recombinant E. coli, as previously described (Paton
et al, 2004). 4EGI-1 was purchased by Bertin bioreagent. HEL and the
peptide HEL 46-61 were purchased from Thermo Fisher Scientific.
Flow cytometry analysis
Cell suspensions were washed and incubated with a cocktail of coupled
specific antibodies for cell surface markers in flow activated cell sorting
(FACS) buffer (PBS, 1% FCS, and 2 mM EDTA) for 30 min at 4°C. For Flt3-l
BMDCs, the antibodies usedwere CD11c (N418), SiglecH (551), CD86 (GL-1),
F4/80 (BM8), CD64 (X54-5/7.1) from BioLegend; Sirpα (P84), CD24 (M1/69),
and MHC II (M5/114.15.2) from eBioscience CD11b (M1/70) from BD Bio-
science. For splenic cells, the antibodies used were NKp46 (29A1.4), CD4
(RM4-5), CD3 (145-2C11), CD11c (N418), CD19 (eBio1D3), CD8α (53-6.7) from
eBioscience, BST2 (927), Ly6G, F4/80, Ly6C fromBioLegend; CD11b (M1/70),
B220 (RA3-6B2), andCD69 (H1.2F3) fromBDBiosciences. These antibodies
were used in combination with the LIVE/DEAD Fixable Aqua Dead Cell
Stain (Thermo Fisher Scientific). For intracellular staining, cells were next
fixed with BD Phosflow Fix Buffer I (BD Biosciences) during 10 min at
room temperature and washed with 10% Perm/wash Buffer I 1× (BD
Biosciences). Permeabilized cells were blocked during 109 with 10%
Perm/wash buffer 1×, 10% FCS, before staining with primary antibodies.
When the primary antibody was not coupled, cells were washed after
and blocked during 10 min with Perm/wash buffer 1×, 10% FCS, and 10%
of serum from the species where the secondary antibodywas produced.
Then, the incubationwith the secondary antibody was performed at 4°C
during 30 min. p-eIF2α(S51) was purchased from ABCAM and
p-eEF2(Thr56) from Cell Signaling and Deoxyribonuclease (DNAse I)
was purchased from Invitrogen. Data were acquired on an LSR-II/
UV instrument using FACS Diva software. The acquired data were
analyzed with FlowJo software (BD Biosciences).
Translation intensity and speed measurement
SUnSET technique tomeasure the intensity of protein synthesis was
used as previously described (Schmidt et al, 2009). Puromycin was
added in the culture medium at 12.5 μg/ml, and the cells were
incubated for 10 min at 37°C and 5% CO2 before harvesting. Cells
were washed with PBS before cell lysis and immunoblotting with
the anti-puromycin 12D10 antibody (Merck Millipore). For flow
cytometry (flow) cells were processed, as described below for the
intracellular staining, using the α-puromycin 12D10 antibody di-
rectly conjugated with Alexa 488 or A647 from Merck Millipore. The
SUnRISE technique was performed as described (Arguello et al,
2018). Samples were treated with 2 μg/ml of harringtonine at dif-
ferent time points (90, 60, 45, 30, 15, and 0 s) and then treated for 10
min with 12.5 μg/ml of puromycin. For the measurement of Cap-
dependent translation, the cells were treated with 4EGI-I (100 μM)
or rocaglamide (RocA-1) (100 nM) for 0.5, 1, 2, or 4 h. Cells were then
incubated for 15 min at 37°C and stained with the 12D10 antibody
(Merk-Millipore).
Gene expression analysis
Total RNA was extracted from the DCs using the RNeasy Mini Kit
(QIAGEN), including a DNA digestion step with RNAse-free DNAse
(QIAGEN), and cDNA was synthesized using the Superscript II Re-
verse Transcriptase (Invitrogen). Quantitative PCR amplification
was performed using SYBR Green PCR master mix (Takara) using 10
ng of cDNA and 200 nM of each specific primer on a 7500 Fast Real-
PCR system (Applied Biosystems). cDNA concentration in each
sample was normalized to GAPDH expression. The primers used for
gene amplification were the following: GADD34 (S 59-GACCCCTCC
AACTCTCCTTC-39, AS 59-CTTCCTCAGCCTCAGCATTC-39); IL-6 (S 59-CAT
GTTCTCTGGGAAATCGTG-39, AS 59-TCCAGTTTGGTAGCATCCATC-39); IFN-β
(S 59-CCCTATGGAGATGACGGAGA-39, AS 59-ACCCAGTGCTGGAGAAATTG-39);
IL-12 (S 59-GGAATGTCTGCGTGCAAGCT-39, AS 59-ACATGCCCACTTGCTGCAT-
39); ATF4 (S 59-AAGGAGGATGCCTTTTCCGGG-39, AS 59-ATTGGGTTCACT
GTCTGAGGG-39); CHOP (S 59-CACTTCCGGAGAGACAGACAG-39, AS 59-ATGA
AGGAGAAGGAGCAGGAG-39); PERK (S 59-CGGATTCATTGAAAGCACCT-39, AS
59-ACGCGATGGGAGTACAAAAC-39); XBP1 (S 59-CCGCAGCACTCAGACTATG-
39, AS 59-GGGTCCAACTTGTCCAGAAT-39); spliced XBP1 (S 59-CTGAGT
CCGCAGCAGGT-39, AS 59-AAACATGACAGGGTCCAACTT-39); GAPDH (S 59-
TGGAGAAACCTGCCAAGTATG-39, AS 59-GTTGAAGTCGCAGGAGACAAC-39);
IL1-β (S 59-TGATGTGCTGCTGCGAGAGATT-39, AS 59-TGCCATTTTGACAGTGA-
39); eIF2Bε (S 59-GAGCCCTGGAGGAACACAGG-39 AS 59-CACCACGTTGT
CCTCATGGC-39); BIP S (59-ATTGGAGGTGGGCAAACCAA-3’ AS 59-TCGCTG
GGCATCATTGAAGT-39).
GSEA
The GSEA was performed using published murine microarray
datasets accessible through the Gene Expression Omnibus re-
pository under the references GSE9810 (Robbins et al, 2008) and
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Figure 7. ISRIB does not inhibit cytokines expression in LPS activated DCs and Macrophages.
(A) IFN-β and IL-6 secretion was measured by Legendplex in WT and PERKΔK Flt3-L BMDCs stimulated with LPS during 4 h. (B) Protein synthesis was measured by
puromycilation and flow in MEFs treated with ISRIB and different the integrated stress response inducing drugs, thapsigargin (Tg), subtilase cytotoxin (SubAB), and
sodium arsenite for indicated times. (C, D) IFN-β, IL-6, IL-10, and TNF secretion was measured by Legendplex in (C) Flt3-L BMDCs and (D) M-CSF BMDM. Data are mean ± SD
(n = 3). Statistical analysis was performed using Wilcoxon test (*P < 0.05 and **P < 0.01).
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Figure 8. PERK inactivation and cytokines expression.
(A) IL-10 and TNF secretion was measured by Legendplex in Flt3-L BMDCs activated with LPS and treated or not with ISRIB or GSK2656157 for 4 h. (B) IL-1β mRNA
expression measured by qRT-PCR (left) and secretion by ELISA (right) in WT and PERKΔK Flt3-L BMDCs stimulated with LPS during 4 h and with ATP for the last 30 min of
treatment. (C) IL-1β mRNA expression measured by qRT-PCR (left) and secretion by ELISA (right) in Flt3-L BMDCs activated with LPS and treated with GSK2656157 and/or
ISRIB for 4 h and with ATP for the last 30 min of treatment. (A, B, C) Statistical analysis was performed using Dunnett’s multiple comparison (A, B) and Wilcoxon test (C).
Data are mean ± SD (n = 3). independent experiments (*P < 0.05, **P < 0.01, and ***P < 0.001).
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Figure 9. eIF2α phosphorylation levels are regulated by G-actin availability.
WT Flt3-L BMDCs were treated with Latrunculin A (50 nM) (Latrunc A) and Jasplakinolide (1 μM) (Jasp) for the indicated times. (A) Levels of p-eIF2α and total eIF2α
detected by immunoblot in Flt3-L BMDCs. (B) Globular actin levels were measured by flow cytometry intracellular staining using a fluorochrome coupled DNAse I protein
in cDC2 population from Flt3-L BMDCs. The graph shows total mean fluorescence intensity levels. (C) Levels of protein synthesis in cDC2 were measured by puromycilation
and flow intracellular staining. Cells were incubated with puromycin 10 min before harvesting. The graph shows total puromycin mean fluorescence intensity levels. WT
and PERKΔK Flt3-L BMDCs were treated with LPS (100 ng/ml), Latrunc A, and Jasp for 4 h. (D) Levels of p-eIF2α and total eIF2αmonitored by immunoblot in Flt3-L BMDCs.
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GSE2389 (Fontenot et al, 2005). Raw microarray data describing
CD8} + cDCs (DC1), CD11b+ cDC (DC2), pDC (plasmacytoid DCs), B
cells, NK cells, CD8+ T cells (Robbins et al, 2008), and CD4+ T cells
(Fontenot et al, 2005) in mice spleen were downloaded. For each of
these cell types, the hybridization was performed using Affymetrix
mouse 4302.0 gene chips. Microarray data were normalized by
Robust Multi-array Average algorithm (Irizarry et al, 2003) using the
oligo BioconductorR package (Carvalho & Irizarry, 2010). Normali-
zation consists of a background correction of raw intensities, a log2
transformation followed by quantile normalization to allow the
comparison of each probe for each array. Before data usage, the
absence of batch effect was assessed by Principal Component
Analysis using ade4R package (Bougeard & Dray, 2018).
GSEA was performed using publicly available gene signatures
reflecting an ISR state (Tables S1–S3). Lists of ATF4 and CHOP target
genes identified by ChIP-seq experiments (Han et al, 2013) have
been used to search for ATF4-dependent and CHOP-dependent
signatures in DCs (Tables S2 and S3). Lists of genes for which a
translational up-regulation after 1 h of thapsigargin (Tg) treatment
and congruent (both transcriptional and translational) up-
regulations after 16 h of Tg treatment (Guan et al, 2017) were
used to search gene expression signatures, respectively, of acute
and/or cISRs in DCs. GSEA was generated using BubbleGUM
(Spinelli et al, 2015). Briefly, GSEA pairwise comparisons are per-
formed for each probe and the multiple testing effects are cor-
rected using a Benjamini–Yekutieli procedure. The corrected
P-values are hence calculated based on a null hypothesis distri-
bution built from the permutations of the gene sets across all the
pairwise comparisons. In our analyses, 10,000 permutations of the
gene sets have been performed to compute the P-values. All results
with a FDR below the threshold of 0.25 have been considered as
significant.
Immunoblotting
Cells were lysed in RIPA buffer (25 mM Tris–HCl, pH 7.6, 150 mM NaCl,
1% NP-40; 1% sodium deoxycholate, 0.1% SDS) supplemented with
Complete Mini Protease Inhibitor Mixture Tablets (Roche), NaF (Ser/
Thr and acidic phosphatase inhibitor), Na3VO4 (Tyr and alkaline
phosphatase inhibitor) and MG132 (proteasome inhibitor). The
nuclear extraction was performed using the Nuclear Extract kit
(Active Motif) according with manufacturer’s instructions. Protein
quantification was performed using the BCA Protein Assay (Pierce).
Around 20 μg of soluble proteins were run in 4–20% acrylamide
gradient gels and for the immunoblot the concentration and time of
incubation had to be optimized for each individual antibody. Rabbit
antibodies against eIF2α, p-eEF2(Thr56), eEF2, eIF2B, p-IRF3 (ser396),
IRF3, p-S6, and PERK were purchased from Cell Signaling (ref 5324,
2331, 2332, 3592, 4947, 4302, 2211, and 3192, respectively). Rabbit
antibody against p-eIF2α(S51) was purchased from ABCAM (Ref
32157). Rabbit antibody against ATF4 was purchased from Santa Cruz
Biotechnology (sc-200). Mouse antibody against β-actin was pur-
chased from Sigma-Aldrich (A2228). Mouse antibodies against
HDAC1 and S6 were purchased from Cell Signaling (ref 5356, 2317,
respectively). Mouse antibody against puromycin was purchased
from Merck Millipore (MABE343). Mouse antibody against p-eIF2β
was a kind gift from David Litchfield (University of Western Ontario).
Mouse antibody against eIF2β was purchased from Santa Cruz
Biotechnology (sc-9978). HRP secondary antibodies were from
Jackson ImmunoResearch Laboratories.
Cytokine measurement
The IL-6, IFN-β, IL1-β, and IL-2 quantifications from the cell culture
supernatant were performed using the mouse Interleukin-6 ELISA
Kit (eBioscience), themouse IFN-β ELISA Kits (PBL-Interferon Source
or Thermo Fisher Scientific), the mouse IL1-β, and mouse IL2 un-
coated ELISA kits (Invitrogen) according to the manufacturer’s
instructions. Cytokine monitoring was also performed using
Legendplex 740150 (BioLegend).
Antigen presentation assays
Flt3-L-differentiated bmDC obtained from C3H/HeN were treated
with indicated concentration of HEL or with 5 μM of 46-61 HEL
peptide and incubated for 8 h with 100 nM of LPS in presence or not
of GSK2656157. DCs were fixed mildly with 0.25% PFA, 2 min, RT, and
prior quenching with 10 mM glycine. DCs were co-cultivated with
3A9 (HEL 46-61 on I-Ak) specific T hybridoma at 5:1 (T:DC) ratio for
18 h. CD69 up-regulation and IL-2 production was determined,
respectively, by cytometry and ELISA.
Immunohistochemistry
Spleens were snap frozen in Tissue Tek (Sakura Finetek). Frozen
sections (8 μm) were fixed with acetone permeabilized with 0.05%
saponin. The following antibodies were used for the staining: CD11c
(N418) from BioLegend (Ref 117301), p-eIF2α (Ser 52) from Invitrogen
(Ref 44-728G), CD11b (M1/70) from BD Biosciences, CD8α-biotin (53-
6.7) BioLegend (Ref 100703), and B220 (RA3-6B2) from Invitrogen (Ref
14-0452-81). Images were collected using a Zeiss LSM 510 confocal
microscope. Image processing was performed with Zeiss LSM
software.
Mice
Wild-type (WT) female C57BL/6 and C3H/HeN mice were purchased
from Janvier. PKR−/− C57BL/6 were a kind gift from Dr Bryan Wil-
liams (Hudson Institute of Medical Research) (Kumar et al, 1997).
PERKloxp/loxp mice were the kind gift of Dr Doug Cavener (Zhang et al,
2006) and purchased from Jackson Laboratories. GADD34ΔCloxp/loxp
mice were developed at the Centre d’Immunophénomique (CIPHE).
Quantification is shown on the right. (E) WT and PERKΔK GM-CSF BMDCs were treated with LPS (100 ng/ml) d—uring 30 min previous to 16 h of migration. The graph
represents instantaneous mean velocities of migration in 4 × 5-μm fibronectin-coated microchannels of at least 100 cells per condition. All data are representative of n = 3
independent experiments. (A, B, C) Statistical analysis was performed using Dunnett’s multiple comparison (A) and Mann–Whitney test (B, C). Data are mean ± SD (n = 3).
*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.
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PERKloxp/loxp and GADD34loxp/loxp were crossed with Itgax-Cre+ mice
(Caton et al, 2007) and backcrossed, to obtain stable homozygotic
lines for the loxp sites expressing Cre. For all studies, age-matched
WT and transgenic 6–9 wk females were used. All animals were
maintained in the animal facility of CIML or CIPHE under specific
pathogen–free conditions accredited by the French Ministry of
Agriculture to perform experiments on livemice. These studies were
carried out in strict accordance with Guide for the Care and Use of
Laboratory Animals of the European Union. All experiments were
approved by the Comité d’Ethique PACA and MESRI (approval
number APAFIS#10010-201902071610358). All efforts were made to
minimize animal suffering.
Preparation of microchannels and speed of migration
measurement
Microchannels were prepared as previously described (Vargas et al,
2016). For velocity measurements (carried out in 4-by-5 µm
microchannels), phase-contrast images of migrating cells were
acquired during 16 h (frame rate of 2 min) on an epifluorescence
Nikon Ti-E video microscope equipped with a cooled charge-
coupled device camera (HQ2; Photometrics) and a 10× objective.
Kymographs ofmigrating cells were generated and analyzed using a
custom program.
Statistical analysis
Statistical analysis was performed using GraphPad Prism Software.
The most appropriate statistical test was chosen according to each
data set. Mainly, we used Wilcoxon test, Mann–Whitney test, t test,
and multiple comparison with Dunnett’s correction. *P < 0.5, **P <
0.01, ***P < 0.001, and ****P < 0.0001.
Supplementary Information
Supplementary Information is available at https://doi.org/10.26508/lsa.
202000865.
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